Join
Live feed
·
PRReleasevia Quantisnow
Alvotech logo

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)

ByQuantisnow·Wall Street's wire, on your screen.
ALVO· Alvotech
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ALVO (Alvotech) and more on Quantisnow.